Form 424B3 ROYAL BANK OF CANADA
Supplement dated September 27, 2022
to the pricing supplements, each dated September 23, 2022,
to the Product Prospectus Supplement No. ERN-ETF-1 Dated
March 3, 2022, the Prospectus Supplement Dated September
14, 2021 and the Prospectus, Dated September 14, 2021
(each, a “Note Prospectus”)
|
Filed pursuant to Rule 424(b)(3)
Registration Statement 333-259205
|
Royal Bank of Canada
Notes Linked to a Basket of Closed-End Funds, due September 26, 2024
Global Medium-Term Notes, Series I
CUSIPS: 78015QBX8 and 78015QBY6
(the “notes”)
|
This document (the “supplement”) supplements each Note Prospectus. Capitalized terms used but not defined in this supplement have the meanings set forth in each Note Prospectus.
The Initial Price for each Basket Component was determined after the close of trading on September 27, 2022, in the manner contemplated by each Note Prospectus. The Initial Price for each Basket
Component is set forth in the table below:
Basket Component
|
Ticker
|
Initial Price
|
|||
BlackRock Energy & Resources Trust
|
BGR
|
$10.45
|
|||
BlackRock Innovation and Growth Trust
|
BIGZ
|
$7.20
|
|||
BlackRock Enhanced Global Dividend Trust
|
BOE
|
$8.83
|
|||
BlackRock Science and Technology Trust II
|
BSTZ
|
$17.98
|
|||
BlackRock Debt Strategies Fund, Inc.
|
DSU
|
$8.93
|
|||
Eaton Vance Enhanced Equity Income Fund
|
EOI
|
$14.34
|
|||
The Gabelli Dividend & Income Trust
|
GDV
|
$19.18
|
|||
Western Asset High Income Opportunity Fund Inc.
|
HIO
|
$3.75
|
|||
PGIM High Yield Bond Fund, Inc.
|
ISD
|
$11.66
|
|||
Nuveen Credit Strategies Income Fund
|
JQC
|
$5.06
|
|||
Nuveen Real Asset Income and Growth Fund
|
JRI
|
$11.40
|
|||
Nuveen Floating Rate Income Opportunity Fund
|
JRO
|
$8.05
|
|||
MainStay CBRE Global Infrastructure Megatrends Fund
|
MEGI
|
$13.51
|
|||
Tekla Healthcare Opportunities Fund
|
THQ
|
$18.20
|
|||
Tri-Continental Corporation
|
TY
|
$25.96
|
Documentation
You should read this supplement, together with the documents listed below, which together contain the terms of the notes and supersede all prior or contemporaneous oral statements as well as any other written materials.
You should carefully consider, among other things, the matters set forth in the section "Selected Risk Considerations" beginning on page P-8 of the applicable Pricing Supplement, and “Additional Risk Factors Specific to the Notes” beginning on page
PS-6 of product supplement ERN-ETF-1, and on page S-2 of the prospectus supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting, and other advisors before
you make any invest decision relating to the notes.
You may access these documents on the SEC website at www.sec.gov as follows:
Pricing Supplement relating to CUSIP 78015QBX8, dated September 23, 2022:
Pricing Supplement relating to CUSIP 78015QBY6, dated September 23, 2022:
Product Prospectus Supplement ERN-ETF-1 dated March 3, 2022:
Prospectus Supplement dated September 14, 2021:
Prospectus dated September 14, 2021:
Our Central Index Key, or CIK, on the SEC website is 1000275. Unless otherwise indicated or unless the context requires otherwise, all references in this supplement to “we,” “us,” “our,” or similar references are to Royal
Bank of Canada.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- iZafe Group's Quarterly Report January-March 2024
- HSBC Continental Europe: Post Stabilisation Notice
- Transaction in own shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!